{"pub_date": "2016-07-13T00:00:00Z", "subsection_name": null, "lead_paragraph": "The government said two deaths that prompted it to stop the study had been caused by a drug used in pretreatment, not the leukemia treatment.", "print_page": "2", "document_type": "article", "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "multimedia": [], "section_name": "Business Day", "headline": {"print_headline": "F.D.A. Allows Resumption  of a Leukemia Drug Trial", "main": "Study of Juno Therapeutics Leukemia Treatment Is Allowed to Resume"}, "source": "The New York Times", "blog": [], "word_count": "195", "web_url": "http://www.nytimes.com/2016/07/13/business/study-of-juno-therapeutics-leukemia-treatment-is-allowed-to-resume.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "The government said two deaths that prompted it to stop the study had been caused by a drug used in pretreatment, not the leukemia treatment....", "_id": "578586c438f0d804dfd9ba01", "abstract": "Food and Drug Administration permits resumption of experimental trial for leukemia treatment by Juno Therapeutics, after modification; two patients had perished from brain swelling. ", "keywords": [{"rank": "1", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}, {"rank": "2", "name": "subject", "value": "Leukemia", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Cancer", "is_major": "N"}, {"rank": "4", "name": "organizations", "value": "Food and Drug Administration", "is_major": "Y"}, {"rank": "5", "name": "organizations", "value": "Juno Therapeutics Inc", "is_major": "Y"}]}